SEC 13F Intelligence

Rhenman & Partners Asset Management AB / CVS

Rhenman & Partners Asset Management AB’s Cvs Health Corp Position

Does Rhenman & Partners Asset Management AB own Cvs Health Corp (CVS)? Yes — 336.5K shares worth $24M (+2.98% of its 13F portfolio) as of Q1 2026, up from 335.5K shares the prior filed quarter.

Position Value
$24M
Q1 2026
Shares
336.5K
% of Portfolio
+2.98%
Quarters Held
28
currently held

Position History CVS

Reported value by quarter
Q4 ’18: $27MQ4 ’18Q1 ’19: $19MQ2 ’19: $19MQ3 ’19: $19MQ4 ’19: $10MQ4 ’19Q1 ’20: $15MQ2 ’20: $15MQ3 ’20: $14MQ4 ’20: $29MQ4 ’20Q1 ’21: $34MQ2 ’21: $32MQ3 ’21: $34MQ4 ’21: $43MQ4 ’21Q1 ’22: $24MQ2 ’22: $27MQ3 ’22: $21MQ4 ’22: $16MQ4 ’22Q1 ’23: $13MQ2 ’23: $17MQ3 ’23: $21MQ4 ’23: $11MQ4 ’23Q3 ’24: $12MQ4 ’24: $12MQ1 ’25: $16MQ2 ’25: $20MQ2 ’25Q3 ’25: $21MQ4 ’25: $27MQ1 ’26: $24Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026336.5K$24M+2.98%
Q4 2025335.5K$27M+2.49%
Q3 2025277.4K$21M+2.31%
Q2 2025295.4K$20M+2.58%
Q1 2025235.9K$16M+1.84%
Q4 2024267.5K$12M+1.23%
Q3 2024184.0K$12M+0.94%
Q4 2023137.5K$11M+1.08%
Q3 2023300.0K$21M+2.26%
Q2 2023248.0K$17M+1.81%
Q1 2023173.0K$13M+1.42%
Q4 2022171.0K$16M+1.66%
Q3 2022225.0K$21M+2.23%
Q2 2022290.0K$27M+3.05%
Q1 2022235.0K$24M+2.35%
Q4 2021410.0K$43M+2.83%
Q3 2021400.0K$34M+2.38%
Q2 2021380.0K$32M+2.15%
Q1 2021450.0K$34M+2.36%
Q4 2020420.0K$29M+2.34%
Q3 2020240.0K$14M+1.25%
Q2 2020227.0K$15M+1.59%
Q1 2020260.0K$15M+2.16%
Q4 2019140.2K$10M+1.14%
Q3 2019303.8K$19M+2.40%
Q2 2019343.8K$19M+2.06%
Q1 2019353.9K$19M+2.23%
Q4 2018408.9K$27M+3.06%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rhenman & Partners Asset Management AB’s full portfolio or all institutional holders of CVS.